Use systems capable of hosting several antiviral drugs and develop innovative therapies to fight SARS-CoV-2.
As a specific medicinal product against SARS-CoV-2 has not yet been identified, an economical and effective therapeutic strategy is to re-use existing drugs that have already shown positive effects on SARS-CoV-2.
The chances of success are relatively good, allowing the project results to be applied against SARS CoV-2 in a relatively short time.The proposed systems are biodegradable and non-toxic, and their large-scale synthesis does not present major problems.
Principal Investigator: Noureddine Khiar el Wahabi (IIQ)
